Potential low-density lipoprotein cholesterol, cardiovascular risk and costs reduction with evolocumab: a simulation in patients with a recent myocardial infarction in Spain

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Risk Factors and Prevention ePosters Drug therapy ESC Premium Access ESC Congress 2021 - The Digital Experience

ESC 365 is supported by

ESC 365 is supported by